{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T00:15:56Z","timestamp":1783296956615,"version":"3.54.6"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T00:00:00Z","timestamp":1777248000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T00:00:00Z","timestamp":1777248000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hypertens Res"],"published-print":{"date-parts":[[2026,7]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Cardiovascular-kidney-metabolic (CKM) syndrome, a recently proposed concept focusing on the interrelationship among cardiovascular system, chronic kidney disease, and metabolic risk factors, is associated with high morbidity and mortality. The mechanism of CKM syndrome has not yet been fully examined due to the lack of an animal model. Here, we investigated whether an adenine-supplemented high-fat diet (AHFD) can induce CKM syndrome in mice. We fed normal chow diet (NCD), adenine-supplemented diet (AD), high-fat diet (HFD), and 0.15% AHFD to 129\u00d71\/Sv mice for 16 weeks and 0.2%AHFD to 129\u00d71\/Sv for 6 weeks. Also, C57BL\/6\u2009N mice were fed with 0.15%AHFD for 16 weeks. Metabolic parameters, blood pressure, organ weights, histology, and RNA sequencing were analyzed. The 0.15%AHFD group exhibited hypercholesterolemia, elevated blood pressure, kidney atrophy with fibrosis, and cardiac hypertrophy with interstitial fibrosis. Both kidney and cardiac RNA sequencing in the 0.15%AHFD group revealed upregulation of inflammatory and immune-related gene sets, whereas genes involved in cardiac contraction were downregulated. In contrast, 0.2%AHFD induced body weight loss, severe kidney dysfunction, and cardiac atrophy without functional impairment in 129\u00d71\/Sv mice. Of note, the C57BL\/6\u2009N mice exhibited metabolic abnormality and cardiac hypertrophy with diastolic dysfunction after 0.15%AHFD feeding despite mild renal dysfunction. We report a novel mouse model of CKM syndrome with dietary intervention, which exhibits fibrosis and myocardial hypertrophy in the heart. This model could be a valuable tool for analyzing the mechanism of CKM syndrome and assessing therapeutic options.<\/jats:p>","DOI":"10.1038\/s41440-026-02645-1","type":"journal-article","created":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T07:47:58Z","timestamp":1777276078000},"page":"2201-2214","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["A novel mouse model of adenine-supplemented high-fat diet induced cardiovascular-kidney-metabolic syndrome"],"prefix":"10.1038","volume":"49","author":[{"given":"Hiroe","family":"Ono","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoichiro","family":"Otaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsu","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryuhei","family":"Yamaguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomohiro","family":"Takehara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shingo","family":"Tachibana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Goto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takanori","family":"Arimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haruki","family":"Ochi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masafumi","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,27]]},"reference":[{"key":"2645_CR1","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.1161\/CIR.0000000000001186","volume":"148","author":"CE Ndumele","year":"2023","unstructured":"Ndumele CE, Neeland IJ, Tuttle KR, Chow SL, Mathew RO, Khan SS, et al. A synopsis of the evidence for the science and clinical management of cardiovascular-kidney-metabolic (CKM) syndrome: a scientific statement from the American Heart Association. Circulation. 2023;148:1636\u201364.","journal-title":"Circulation"},{"key":"2645_CR2","doi-asserted-by":"publisher","first-page":"1858","DOI":"10.1001\/jama.2024.6892","volume":"331","author":"R Aggarwal","year":"2024","unstructured":"Aggarwal R, Ostrominski JW, Vaduganathan M. Prevalence of cardiovascular-kidney-metabolic syndrome stages in US adults, 2011-2020. JAMA. 2024;331:1858\u201360.","journal-title":"JAMA"},{"key":"2645_CR3","doi-asserted-by":"publisher","first-page":"2608","DOI":"10.1016\/j.ekir.2024.05.033","volume":"9","author":"ZA Massy","year":"2024","unstructured":"Massy ZA, Drueke TB. Combination of cardiovascular, kidney, and metabolic diseases in a syndrome named cardiovascular-kidney-metabolic, with new risk prediction equations. Kidney Int Rep. 2024;9:2608\u201318.","journal-title":"Kidney Int Rep"},{"key":"2645_CR4","doi-asserted-by":"publisher","first-page":"e840","DOI":"10.1161\/CIR.0000000000000664","volume":"139","author":"J Rangaswami","year":"2019","unstructured":"Rangaswami J, Bhalla V, Blair JEA, Chang TI, Costa S, Lentine KL, et al. Cardiorenal syndrome: classification, pathophysiology, diagnosis, and treatment strategies: a scientific statement from the American Heart Association. Circulation. 2019;139:e840\u2013e78.","journal-title":"Circulation"},{"key":"2645_CR5","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.1016\/j.jacc.2008.07.051","volume":"52","author":"C Ronco","year":"2008","unstructured":"Ronco C, Haapio M, House AA, Anavekar N, Bellomo R. Cardiorenal syndrome. J Am Coll Cardiol. 2008;52:1527\u201339.","journal-title":"J Am Coll Cardiol"},{"key":"2645_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2022.102459","volume":"56","author":"J Wollenhaupt","year":"2022","unstructured":"Wollenhaupt J, Frisch J, Harlacher E, Wong DWL, Jin H, Schulte C, et al. Pro-oxidative priming but maintained cardiac function in a broad spectrum of murine models of chronic kidney disease. Redox Biol. 2022;56:102459.","journal-title":"Redox Biol"},{"key":"2645_CR7","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1038\/s41586-019-1100-z","volume":"568","author":"GG Schiattarella","year":"2019","unstructured":"Schiattarella GG, Altamirano F, Tong D, French KM, Villalobos E, Kim SY, et al. Nitrosative stress drives heart failure with preserved ejection fraction. Nature. 2019;568:351\u20136.","journal-title":"Nature"},{"key":"2645_CR8","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.vascn.2016.10.007","volume":"84","author":"S Nath","year":"2017","unstructured":"Nath S, Ghosh SK, Choudhury Y. A murine model of type 2 diabetes mellitus developed using a combination of high fat diet and multiple low doses of streptozotocin treatment mimics the metabolic characteristics of type 2 diabetes mellitus in humans. J Pharm Toxicol Methods. 2017;84:20\u201330.","journal-title":"J Pharm Toxicol Methods"},{"key":"2645_CR9","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1186\/1471-2369-14-116","volume":"14","author":"T Jia","year":"2013","unstructured":"Jia T, Olauson H, Lindberg K, Amin R, Edvardsson K, Lindholm B, et al. A novel model of adenine-induced tubulointerstitial nephropathy in mice. BMC Nephrol. 2013;14:116.","journal-title":"BMC Nephrol"},{"key":"2645_CR10","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1093\/ndt\/gfad215","volume":"39","author":"Z Makhammajanov","year":"2024","unstructured":"Makhammajanov Z, Gaipov A, Myngbay A, Bukasov R, Aljofan M, Kanbay M. Tubular toxicity of proteinuria and the progression of chronic kidney disease. Nephrol Dial Transpl. 2024;39:589\u201399.","journal-title":"Nephrol Dial Transpl"},{"key":"2645_CR11","doi-asserted-by":"publisher","first-page":"761","DOI":"10.2215\/CJN.08560816","volume":"12","author":"M Park","year":"2017","unstructured":"Park M, Hsu CY, Go AS, Feldman HI, Xie D, Zhang X, et al. Urine Kidney injury biomarkers and risks of cardiovascular disease events and all-cause death: the CRIC study. Clin J Am Soc Nephrol. 2017;12:761\u201371.","journal-title":"Clin J Am Soc Nephrol"},{"key":"2645_CR12","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1053\/j.ajkd.2014.07.025","volume":"65","author":"KD Liu","year":"2015","unstructured":"Liu KD, Yang W, Go AS, Anderson AH, Feldman HI, Fischer MJ, et al. Urine neutrophil gelatinase-associated lipocalin and risk of cardiovascular disease and death in CKD: results from the Chronic Renal Insufficiency Cohort (CRIC) Study. Am J Kidney Dis. 2015;65:267\u201374.","journal-title":"Am J Kidney Dis"},{"key":"2645_CR13","doi-asserted-by":"crossref","unstructured":"Otaki Y, Watanabe T, Shimizu M, Tachibana S, Sato J, Kobayashi Y, et al. Renal tubular damage and clinical outcome in heart failure with preserved ejection fraction and chronic kidney disease. ESC Heart Fail. 2023;10;2458\u201368.","DOI":"10.1002\/ehf2.14378"},{"key":"2645_CR14","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.124.035608","volume":"14","author":"S Tachibana","year":"2025","unstructured":"Tachibana S, Otaki Y, Watanabe T, Goto J, Ochi H, Tanaka T, et al. Diacylglycerol kinase zeta attenuates doxorubicin-induced cardiotoxicity through p53 degradation. J Am Heart Assoc. 2025;14:e035608.","journal-title":"J Am Heart Assoc"},{"key":"2645_CR15","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1038\/s41587-019-0201-4","volume":"37","author":"D Kim","year":"2019","unstructured":"Kim D, Paggi JM, Park C, Bennett C, Salzberg SL. Graph-based genome alignment and genotyping with HISAT2 and HISAT-genotype. Nat Biotechnol. 2019;37:907\u201315.","journal-title":"Nat Biotechnol"},{"key":"2645_CR16","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1093\/bioinformatics\/btt656","volume":"30","author":"Y Liao","year":"2014","unstructured":"Liao Y, Smyth GK, Shi W. featureCounts: an efficient general purpose program for assigning sequence reads to genomic features. Bioinformatics. 2014;30:923\u201330.","journal-title":"Bioinformatics"},{"key":"2645_CR17","doi-asserted-by":"publisher","DOI":"10.1186\/s12859-018-2486-6","volume":"19","author":"SX Ge","year":"2018","unstructured":"Ge SX, Son EW, Yao R. iDEP: an integrated web application for differential expression and pathway analysis of RNA-Seq data. BMC Bioinforma. 2018;19:534.","journal-title":"BMC Bioinforma"},{"key":"2645_CR18","doi-asserted-by":"crossref","unstructured":"Piirsalu M, Taalberg E, Jayaram M, Lillev\u00e4li K, Zilmer M, Vasar E. Impact of a high-fat diet on the metabolomics profile of 129S6 and C57BL6 mouse strains. Int J Mol Sci. 2022;23:11682.","DOI":"10.3390\/ijms231911682"},{"key":"2645_CR19","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1007\/s10741-011-9279-6","volume":"17","author":"MK Szymanski","year":"2012","unstructured":"Szymanski MK, de Boer RA, Navis GJ, van Gilst WH, Hillege HL. Animal models of cardiorenal syndrome: a review. Heart Fail Rev. 2012;17:411\u201320.","journal-title":"Heart Fail Rev"},{"key":"2645_CR20","volume":"2016","author":"A Heydemann","year":"2016","unstructured":"Heydemann A. An overview of murine high fat diet as a model for type 2 diabetes mellitus. J Diab Res. 2016;2016:2902351.","journal-title":"J Diab Res"},{"key":"2645_CR21","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.690517","volume":"8","author":"C Chen","year":"2021","unstructured":"Chen C, Xie C, Wu H, Wu L, Zhu J, Mao H, et al. Uraemic cardiomyopathy in different mouse models. Front Med (Lausanne). 2021;8:690517.","journal-title":"Front Med (Lausanne)"},{"key":"2645_CR22","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/j.kint.2021.10.025","volume":"101","author":"J Soppert","year":"2022","unstructured":"Soppert J, Frisch J, Wirth J, Hemmers C, Boor P, Kramann R, et al. A systematic review and meta-analysis of murine models of uremic cardiomyopathy. Kidney Int. 2022;101:256\u201373.","journal-title":"Kidney Int"},{"key":"2645_CR23","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1681\/ASN.2019080827","volume":"31","author":"BM Klinkhammer","year":"2020","unstructured":"Klinkhammer BM, Djudjaj S, Kunter U, Palsson R, Edvardsson VO, Wiech T, et al. Cellular and molecular mechanisms of kidney injury in 2,8-dihydroxyadenine nephropathy. J Am Soc Nephrol. 2020;31:799\u2013816.","journal-title":"J Am Soc Nephrol"},{"key":"2645_CR24","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1186\/s12882-018-1155-3","volume":"19","author":"JE Kieswich","year":"2018","unstructured":"Kieswich JE, Chen J, Alliouachene S, Caton PW, McCafferty K, Thiemermann C, et al. A novel model of reno-cardiac syndrome in the C57BL\/ 6 mouse strain. BMC Nephrol. 2018;19:346.","journal-title":"BMC Nephrol"},{"key":"2645_CR25","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1186\/s12933-015-0286-0","volume":"14","author":"NW Roberts","year":"2015","unstructured":"Roberts NW, Gonz\u00e1lez-Vega M, Berhanu TK, Mull A, Garc\u00eda J, Heydemann A. Successful metabolic adaptations leading to the prevention of high fat diet-induced murine cardiac remodeling. Cardiovasc Diabetol. 2015;14:127.","journal-title":"Cardiovasc Diabetol"},{"key":"2645_CR26","doi-asserted-by":"publisher","first-page":"e60931","DOI":"10.1371\/journal.pone.0060931","volume":"8","author":"SD Calligaris","year":"2013","unstructured":"Calligaris SD, Lecanda M, Solis F, Ezquer M, Guti\u00e9rrez J, Brandan E, et al. Mice long-term high-fat diet feeding recapitulates human cardiovascular alterations: an animal model to study the early phases of diabetic cardiomyopathy. PLoS One. 2013;8:e60931.","journal-title":"PLoS One"},{"key":"2645_CR27","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.1007\/s10753-024-01981-z","volume":"47","author":"T Chen","year":"2024","unstructured":"Chen T, Xie Q, Tan B, Yi Q, Xiang H, Wang R, et al. Inhibition of pyruvate dehydrogenase kinase 4 protects cardiomyocytes from lipopolysaccharide-induced mitochondrial damage by reducing lactate accumulation. Inflammation. 2024;47:1356\u201370.","journal-title":"Inflammation"},{"key":"2645_CR28","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1007\/s10557-020-07071-0","volume":"34","author":"A Hanna","year":"2020","unstructured":"Hanna A, Frangogiannis NG. Inflammatory cytokines and chemokines as therapeutic targets in heart failure. Cardiovasc Drugs Ther. 2020;34:849\u201363.","journal-title":"Cardiovasc Drugs Ther"},{"key":"2645_CR29","doi-asserted-by":"crossref","unstructured":"Lotfollahzadeh S, Paul H, Bonifacio J, Almiron R, Hockestra I, Przekop K, et al. A murine model of cardiovascular-kidney-metabolic syndrome demonstrates compromised limb function in the ischemic hind limb. Kidney360. 2026;7:233\u201346.","DOI":"10.34067\/KID.0000000900"},{"key":"2645_CR30","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1038\/s41684-024-01457-5","volume":"53","author":"L Carvalho","year":"2024","unstructured":"Carvalho L, Shimari M, Boeder AM, Zhuge Z, Cai M, Leijding C, et al. A novel model of cardiovascular-kidney-metabolic syndrome combining unilateral nephrectomy and high-salt-sugar-fat diet in mice. Lab Anim (NY). 2024;53:336\u201346.","journal-title":"Lab Anim (NY)"},{"key":"2645_CR31","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.jacc.2013.02.092","volume":"62","author":"WJ Paulus","year":"2013","unstructured":"Paulus WJ, Tschope C. A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation. J Am Coll Cardiol. 2013;62:263\u201371.","journal-title":"J Am Coll Cardiol"},{"key":"2645_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.cpcardiol.2023.102344","volume":"49","author":"SA Sebastian","year":"2024","unstructured":"Sebastian SA, Padda I, Johal G. Cardiovascular-Kidney-Metabolic (CKM) syndrome: a state-of-the-art review. Curr Probl Cardiol. 2024;49:102344.","journal-title":"Curr Probl Cardiol"},{"key":"2645_CR33","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1161\/CIRCULATIONAHA.120.050686","volume":"143","author":"J Jankowski","year":"2021","unstructured":"Jankowski J, Floege J, Fliser D, B\u00f6hm M, Marx N. Cardiovascular disease in chronic kidney disease: pathophysiological insights and therapeutic options. Circulation. 2021;143:1157\u201372.","journal-title":"Circulation"},{"key":"2645_CR34","doi-asserted-by":"publisher","first-page":"1786","DOI":"10.1093\/ckj\/sfad085","volume":"16","author":"CVC Junho","year":"2023","unstructured":"Junho CVC, Frisch J, Soppert J, Wollenhaupt J, Noels H. Cardiomyopathy in chronic kidney disease: clinical features, biomarkers and the contribution of murine models in understanding pathophysiology. Clin Kidney J. 2023;16:1786\u2013803.","journal-title":"Clin Kidney J"},{"key":"2645_CR35","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1038\/nrendo.2015.216","volume":"12","author":"G Jia","year":"2016","unstructured":"Jia G, DeMarco VG, Sowers JR. Insulin resistance and hyperinsulinaemia in diabetic cardiomyopathy. Nat Rev Endocrinol. 2016;12:144\u201353.","journal-title":"Nat Rev Endocrinol"},{"key":"2645_CR36","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1161\/CIRCRESAHA.121.318093","volume":"128","author":"M Koenen","year":"2021","unstructured":"Koenen M, Hill MA, Cohen P, Sowers JR. Obesity, adipose tissue and vascular dysfunction. Circ Res. 2021;128:951\u201368.","journal-title":"Circ Res"}],"container-title":["Hypertension Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41440-026-02645-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41440-026-02645-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41440-026-02645-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T00:05:45Z","timestamp":1783296345000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41440-026-02645-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,27]]},"references-count":36,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["2645"],"URL":"https:\/\/doi.org\/10.1038\/s41440-026-02645-1","relation":{},"ISSN":["0916-9636","1348-4214"],"issn-type":[{"value":"0916-9636","type":"print"},{"value":"1348-4214","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,27]]},"assertion":[{"value":"9 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 February 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 April 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 April 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}